Business

Celyad Oncology SA: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, September 04, 2025--Regulatory News: Celyad Oncology (Euronext: CYAD) ("Celyad" or the "Company"), today announced that 3,849,040 registered shares benefit from a double voting right as of September 4, 2025. As a result, the Company’s total number of voting rights is now 61,335,454.

articleCelyad Oncology SaSeptember 4, 20254/company/celyad-oncology-sa/news/celyad-oncology-sa-information-on-the-total-number-of-voting-rights-and-shares-article-15-of-the-law-of-2-may-2007
Celyad Oncology SA: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

About this update from Celyad Oncology Sa

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/f915bda800e94f23eb10404fc6f2c73f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Y41d.NtqFa2pyQBxT2Lnbg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/f915bda800e94f23eb10404fc6f2c73f","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/SXE4m3vYaul82JVJ34R0Ww--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/f915bda800e94f23eb10404fc6f2c73f","width":1024,"height":512}},"lazy":false},{"type":"text","content":"MONT-SAINT-GUIBERT, Belgium, September 04, 2025--(BUSINESS WIRE)--Regulatory News:","length":82,"tagName":"p"},{"type":"text","content":"Celyad Oncology (Euronext: CYAD) ("Celyad" or the "Company"), today announced that 3,849,040 registered shares benefit from a double voting right as of September 4, 2025. As a result, the Company’s total number of voting rights is now 61,335,454.","length":266,"tagName":"p"},{"type":"text","content":"This information is published in accordance with Article 15 of the Belgian Law of 2 May 2007 on the disclosure of major participations in issuers whose shares are admitted to trading on a regulated market and regarding miscellaneous provisions.","length":244,"tagName":"p"},{"type":"text","content":"Figures – Modified on September 4, 2025, following the Double Voting Rights:","length":76,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"colspan":"1","rowspan":"1","style":"vertical-align:top;border-top:solid black 1.0pt;border-bottom:solid black 1.0pt;border-left:solid black 1.0pt;border-right:solid black 1.0pt;width:85%;padding-left:5.0px;","val":[{"type":"text","content":"Total amount of share capital (EUR)","length":35,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"border-top:solid black 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding-left:0.0px;padding-right:0.0px;vertical-align:bottom;padding-bottom:4.0px;text-align:center;list-style-position:inside;width:15%;white-space:nowrap;","val":[{"type":"text","content":"9,216,154.53","length":12,"tagName":"p","attribs":{}}]}]},{"val":[{"c...

More updates from Celyad Oncology Sa

The Companyvoting rightOncologyCompany